{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2017 in Review

Purpose of Activity

To acquaint clinicians with several new primary care drugs approved by the FDA during the first half of 2017.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify indications and contraindications for each drug discussed.
  2. Discuss administration, adverse reactions, and monitoring requirements related to the medications.
Price: $17.95


  • ACPE 1.0 CEU
  • ANCC 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH
  • ANCC 1.5 CH

Awarded Advanced Pharmacology Hours

It is important to identify, resolve, and prevent medication-related problems among home care clients to minimize hospitalizations and emergency room visits. This article discusses a pharmacist-nurse collaborative model in the management of home care clients' medications.

Accreditation Statement:
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: NP1217-Pharm
Published: July 2018
Expires: 11/29/2021
Passing Score: 13/18 (72%)
Authors: Geoffrey Mospan, PharmD, BCPS; Cortney Mospan, PharmD, BCACP, BCGP; Shayna Vance; Alyssa Bradshaw; Kalyn Meosky; Kirklin Bowles
Categories: Drug Therapy